| |
| |
|
| Insider
Information: |
Kearney Terrence C |
| Relationship: |
Director |
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
50,368 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,361,625 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
50,368 |
|
|
| Total
Value |
$4,361,625 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Director |
2015-04-24 |
37,083 |
2014-10-30 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2023-08-10 |
6,536 |
2015-04-27 |
0 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
2021-01-29 |
6,749 |
2017-03-02 |
0 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
Director |
2018-05-15 |
0 |
2018-03-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-08-10 |
4 |
AS |
$350.00 |
$3,500,000 |
D/D |
(10,000) |
6,536 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-08-10 |
4 |
OE |
$127.54 |
$1,275,400 |
D/D |
10,000 |
16,536 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
725 |
6,536 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,622 |
6,749 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2020-10-12 |
4 |
AS |
$117.82 |
$4,475,981 |
D/D |
(37,500) |
5,127 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2020-10-12 |
4 |
OE |
$27.97 |
$1,073,375 |
D/D |
37,500 |
42,627 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2020-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,377 |
5,127 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-11-01 |
4 |
AS |
$200.00 |
$10,121,400 |
D/D |
(50,607) |
5,811 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-11-01 |
4 |
OE |
$56.99 |
$3,756,367 |
D/D |
47,448 |
12,884 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-10-31 |
4 |
AS |
$200.00 |
$368,200 |
D/D |
(1,841) |
8,970 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,381 |
10,811 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
3,750 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,801 |
8,430 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Director |
– • – |
2018-05-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,106) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Director |
– • – |
2018-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,106 |
1,106 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
2,500 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,188 |
6,629 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.01 |
$29 |
D/D |
2,941 |
4,441 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-05-19 |
4 |
OE |
$56.99 |
$85,485 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-04-27 |
4 |
AS |
$127.50 |
$8,795,285 |
D/D |
(68,125) |
0 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-04-27 |
4 |
OE |
$53.85 |
$3,870,844 |
D/D |
68,125 |
68,125 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
13,950 |
37,083 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2014-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,133 |
23,133 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
